INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$11.18

Market cap

$761.65M

P/E Ratio

3.64

Dividend/share

N/A

EPS

$3.07

Enterprise value

$1.01B

Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.

Highlights
The stock's price to earnings (P/E) is 39% less than its 5-year quarterly average of 6.0 and 39% less than its last 4 quarters average of 6.0
Innoviva's quick ratio has plunged by 95% YoY but it has increased by 15% from the previous quarter
The equity has increased by 36% year-on-year but it has declined by 12% since the previous quarter
The debt has grown by 37% YoY
The company's EPS fell by 29% QoQ and by 5% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inva.com
Peers: OCUP

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
68.13M
Market cap
$761.65M
Enterprise value
$1.01B
Valuations
Price to earnings (P/E)
3.64
Price to book (P/B)
1.38
Price to sales (P/S)
2.35
EV/EBIT
3.41
EV/EBITDA
3.2
EV/Sales
3.05
Earnings
Revenue
$331.34M
EBIT
$296.4M
EBITDA
$315.91M
Free cash flow
$201.66M
Per share
EPS
$3.07
Free cash flow per share
$2.9
Book value per share
$8.11
Revenue per share
$4.76
TBVPS
$13.67
Balance sheet
Total assets
$1.23B
Total liabilities
$665.71M
Debt
$540.37M
Equity
$565.79M
Working capital
$308.54M
Liquidity
Debt to equity
0.96
Current ratio
3.29
Quick ratio
2.63
Net debt/EBITDA
0.79
Margins
EBITDA margin
95.3%
Gross margin
95.8%
Net margin
64.6%
Operating margin
141.9%
Efficiency
Return on assets
17.8%
Return on equity
43.2%
Return on invested capital
26%
Return on capital employed
27%
Return on sales
89.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
-2.44%
1 week
3.61%
1 month
-9.98%
1 year
-41.98%
YTD
-15.62%
QTD
-15.62%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$331.34M
Gross profit
$317.55M
Operating income
$470.32M
Net income
$213.92M
Gross margin
95.8%
Net margin
64.6%
The operating margin has increased by 50% YoY but it has decreased by 4.1% from the previous quarter
INVA's operating income is up by 27% YoY but it is down by 15% QoQ
INVA's net income is down by 27% since the previous quarter and by 20% year-on-year
The gross profit is down by 19% YoY and by 14% from the previous quarter

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
P/E
3.64
P/B
1.38
P/S
2.35
EV/EBIT
3.41
EV/EBITDA
3.2
EV/Sales
3.05
The stock's price to earnings (P/E) is 39% less than its 5-year quarterly average of 6.0 and 39% less than its last 4 quarters average of 6.0
The company's EPS fell by 29% QoQ and by 5% YoY
The P/B is 65% below the 5-year quarterly average of 3.9 and 40% below the last 4 quarters average of 2.3
The equity has increased by 36% year-on-year but it has declined by 12% since the previous quarter
The P/S is 45% lower than the 5-year quarterly average of 4.3 and 13% lower than the last 4 quarters average of 2.7
The revenue has contracted by 15% YoY and by 11% from the previous quarter

Efficiency

How efficient is Innoviva business performance
INVA's ROA is down by 38% YoY and by 32% from the previous quarter
INVA's return on equity is down by 32% since the previous quarter and by 28% year-on-year
The return on invested capital has declined by 22% since the previous quarter and by 18% year-on-year
The company's return on sales fell by 13% QoQ and by 2.9% YoY

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 85% greater than the total liabilities
Innoviva's quick ratio has plunged by 95% YoY but it has increased by 15% from the previous quarter
The company's current ratio has shrunk by 94% YoY but it rose by 19% QoQ
The debt is 4.5% less than the equity
The debt has grown by 37% YoY
The equity has increased by 36% year-on-year but it has declined by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.